A tissue biomarker panel predicting systemic progression after PSA recurrence post-definitive prostate cancer therapy.

A tissue biomarker panel predicting systemic progression after PSA recurrence post-definitive prostate cancer therapy.

BACKGROUND:Many men develop a rising PSA after initial therapy for prostate cancer. While some of these men will develop a local or metastatic recurrence that warrants further therapy, others will have no evidence of disease progression. We hypothesized that an expression biomarker panel can predict...

Full description

Bibliographic Details
Main Authors: Tohru Nakagawa, Thomas M Kollmeyer, Bruce W Morlan, S Keith Anderson, Eric J Bergstralh, Brian J Davis, Yan W Asmann, George G Klee, Karla V Ballman, Robert B Jenkins
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2008-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18846227/pdf/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18846227/pdf/?tool=EBI

Similar Items